A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant
Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant
CHMP recommends Moderna's flu-Covid shot and Novartis pill for hives
CHMP recommends Moderna's flu-Covid shot and Novartis pill for hives
Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more
Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more
Reversal on Moderna's flu application follows atypical path through FDA
Reversal on Moderna's flu application follows atypical path through FDA
FDA reverses course, will review Moderna’s flu vaccine
FDA reverses course, will review Moderna’s flu vaccine
Moderna faces setback in Arbutus' mRNA patent fight
Moderna faces setback in Arbutus' mRNA patent fight
Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more
Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more
Moderna's flu shot dilemma muddies 2028 break-even guidance
Moderna's flu shot dilemma muddies 2028 break-even guidance
FDA may consider Moderna's flu vaccine in a narrower group
FDA may consider Moderna's flu vaccine in a narrower group
Prasad overruled vaccine review team, office director on Moderna flu shot
Prasad overruled vaccine review team, office director on Moderna flu shot
Moderna accuses FDA of shifting standard as agency refuses flu shot review
Moderna accuses FDA of shifting standard as agency refuses flu shot review
#JPM26: Moderna CEO Bancel talks deals, flu and RSV strategy
#JPM26: Moderna CEO Bancel talks deals, flu and RSV strategy
Moderna seeks flu vaccine approvals; Neumora Alzheimer's data
Moderna seeks flu vaccine approvals; Neumora Alzheimer's data
Sarepta ends Elevidys trial with Hansa's pre-treatment; Some pipeline cuts at Moderna
Plus, news about Blue Lake, Bambusa, Inhibikase Therapeutics and Olema Oncology: 🛑 Sarepta terminates Elevidys trial with Hansa Biopharma’s imlifidase: The study was e...
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page